Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
|
... ibandronate, pamidronate, risedronate, tiludronate, and zoledronic acid, are used to treat osteoporosis, to slow bone turnover in patients with Paget disease, and to treat bone metastases and lower excess blood calcium levels in patients with ...
|
|
Scientists from deCODE genetics and colleagues from Australia and Denmark report the discovery of common single-letter variations in the human genome linked to low bone mineral density , the clinical ...
|
|
Pathology Quiz Case: Diagnosis Diagnosis: Sinonasal osteosarcoma Osteosarcoma is the most common primary malignant neoplasm of the bone, with a reported incidence of 1 per 100 000, 6% to 10% of which present ...
|
|
The American Society for Bone and Mineral Research , the leading scientific organization for the study of bone diseases, announces the publication of the new seventh edition of the Primer on the Metabolic Bone ...
|
|
... been in patients with cancer who were receiving much higher doses than those used to treat osteoporosis or Paget disease of bone. The risk, if any, to patients with these latter conditions receiving these drugs appears to be very small. Recently ...
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.